2021-11-16-世界卫生组织-Cervical_cancer_Brunei_Darussalam_2021_country_profile_1页_65kb

Brunei Darussalam Cervical Cancer Profile Summary

This report provides an overview of cervical cancer in Brunei Darussalam based on available data up to 2021. Key areas include morbidity and mortality, primary prevention through HPV vaccination, secondary prevention via screening, treatment availability, and efforts toward WHO elimination targets by 2030.

Morbidity and Mortality

• Crude cervical cancer incidence rate among women was 25.7 per 100,000 in 2020.
• Age-standardized incidence rate was 20.8 per 100,000 in 2020.
• Cumulative lifetime risk of cervical cancer from ages 0 to 74 was approximately 2.1% in 2020.
• Cervical cancer deaths were 1,000 in 2019.
• Mortality-to-incidence ratio stood at 0.26 in 2020.
• A population-based cancer registry exists as of 2021.

Primary Prevention

• HPV vaccination coverage among girls at final dose was 92% in 2020.
• The HPV vaccination program was introduced in 2012, targeting girls aged 15 years as final dose.
• Full vaccination coverage by age 15 was 89%, with doses starting at age 13.
• HPV is included in the national vaccination program.
• Scale of coverage was high, with programs available in schools.
• Related risk factors: Tobacco use prevalence among women 15 and above was 2.1% in 2020 (only smoking data available), condom use at last high-risk sex is not specified, and HIV incidence among women 15 and above was not available.

Secondary Prevention: Screening

• A national cervical cancer screening program exists as of 2021.
• The primary screening test used is cytology.
• Target age range for screening is 20 to 65 years.
• Guidelines for strengthening early detection in primary healthcare are unclear or not specified as of 2021.
• A clearly defined referral system from primary to secondary and tertiary care exists as of 2021.

Treatment and Supportive Care

• National guidelines on cervical cancer management exist as of 2021.
• Radiotherapy and brachytherapy units were limited: Specifically, radiotherapy units available were 8 per 10,000 cancer patients in 2020.
• Cancer diagnosis and treatment services: Medical staff availability per 10,000 cancer patients were low, ranging from surgeons to nuclear medicine physicians missing or not fully specified.
  • Radiation oncologists data missing.
  • Medical physicists not available in data.
  • Chemotherapy and radiologists specified as available, but numbers incomplete.
• Access to cancer centers or departments at tertiary level exists.
• Palliative care for non-communicable diseases is available through the public health system in principle, but data on opioid consumption details missing.

WHO Elimination Strategy Targets for 2030

• Data indicate that 32% of women aged 30–49 were screened with high-performance tests by 35 years, and 70% of cervical cancer cases received treatment.

Overall, Brunei has a cervical cancer control program with primary prevention through HPV vaccination and some screening and treatment facilities, but deficiencies exist in detailed treatment resources and complete data on certain areas.